The Glanzmann’s Research Foundation exists to increase awareness of Glanzmann’s Thrombasthenia, provide a network of support for families navigating through a GT diagnosis, and raise funding to find a cure.
If you have found the GRF because you or a loved one have recently been diagnosed with GT, we want to let you know that you are not alone. We have a vibrant community of GT patients and their caregivers who are ready to share their stories, experiences, and remedies with you.
Here is a list of conditions this partner raises awareness and advocacy for:
Julia Smith was diagnosed with Glanzmann thrombasthenia (GT) at the tender young age of six months through a series of fortunate events. First, her mother Helen,
Glanzmann’s thrombasthenia (GT) is an inherited autosomal disorder that begins at birth. It causes prolonged or spontaneous bleeding and affects one out of one million people. Patients
Has anyone ever called you one in a million? You took it as a compliment, no doubt. Maybe you saw this as someone saying that
To read our primer on Hemophilia, click here and to read our primer on von Willebrand click here. These next three bleeding disorders – grouped under
In a news release from May 18, 2021, biopharmaceutical company Catalyst Biosciences, Inc. (“Catalyst”) shared that the first patient was dosed in the Phase
The 17th Annual Congress of the European Association for Haemophilia and Allied Disorders took place this year from February 6-9, 2024. During the Congress, stakeholders
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
